Results 101 to 110 of about 32,408 (167)

RAPTOR Silencing Inhibits Head and Neck Squamous Cell Carcinoma Progression via Regulation of S100A8/A9 and Urokinase Plasminogen Activator. [PDF]

Med Sci Monit
Fu Z, Wang S, Zheng H, Wu H, Li T, Wang L, Li H, Zhang Q.   +7 more
europepmc   +1 more source

Biomarker-Stratified Efficacy of Immune Checkpoint Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized Trials. [PDF]

Cancers (Basel)
Srinivasmurthy R, Jones DT, Nanda RK, Ta J, Hussain A, Hattin R, Tian S, Shah S, Bigcas JL, Wang R, Francis S, Thein KZ.   +11 more
europepmc   +1 more source

Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer. [PDF]

Clin Cancer Res
Prasad M, Cheng AT, Mayer M, Jansen L, Koh E, Nadeem Z, Sivan Pillai G, Vos J, Kuo F, Zhao K, Sfreddo HJ, Lee A, Chen S, Schloss J, Deng X, Jain S, Muldoon D, Bandlamudi C, Klussmann JP, Ow TJ, Ho AL, Lee NY, Riaz N, Wong RJ, Ganly I, Katabi N, Morris LGT.   +26 more
europepmc   +1 more source

Prognostic Impact of miR-34a in Head and Neck Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis and Trial Sequential Analysis. [PDF]

Int J Mol Sci
Dioguardi M, Cantore S, Guerra C, Sovereto D, Camerino GP, Martella A, Piccinonno R, Lo Muzio A, Boccellino M, Lo Muzio L, Ballini A, De Rosa A.   +11 more
europepmc   +1 more source

Perioperative immunotherapy in resectable HNSCC: biological rationale to practical multidisciplinary implementation. [PDF]

Front Oncol
Bila M, Vander Poorten V, Meulemans J, Huvenne W, De Vos W, Willaert R, De Ceulaer J, Clement PM.   +7 more
europepmc   +1 more source

CDCSI: a machine learning-based interpretable cell death and cellular senescence index for prognosis improvement, immune landscape characterization, and therapeutic response prediction in head and neck squamous cell carcinoma. [PDF]

Front Immunol
Luo X, He X.
europepmc   +1 more source

Integrative Analysis of FADS3 in HNSCC

International Dental Journal
Haonan Tang, Keyi Wang, Yuchi Zhu, Yuan Fan, Yanting Wang   +4 more
openaire   +1 more source

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study. [PDF]

Signal Transduct Target Ther
Guo Y, Li Z, Xue L, Lin J, Qu S, Sun C, Fang M, Zhu Y, Zong J, Chen W, Cao G, Wu J, Ge M, Li Z, Wang S, Wang X, Jiang H, Hu D, Shen L, Wei Y, Jin C, Zhang H, Huang X, Sun Y, Shi J, Wang M, Luo X, Kuang S, Wei S, Deng R, Shen Y.   +30 more
europepmc   +1 more source

<i>SLC39A13</i> Defines Myofibroblastic Activation and Immunosuppressive Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. [PDF]

Curr Oncol
Takahashi H, Hagiwara H, Tada H, Uchida M, Matsuyama T, Chikamatsu K.   +5 more
europepmc   +1 more source

A unified single-cell atlas of HNSCC: Toward characterizing HPV- and sex-associated TME variability. [PDF]

iScience
Conde-Lopez C, Marripati D, Besso MJ, Roscher M, Han R, Hadiwikarta WW, Elkabets M, Hess J, Kurth I.   +8 more
europepmc   +1 more source